Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JP Morgan Maintains Overweight on Replimune Group, Lowers Price Target to $39

JP Morgan analyst Anupam Rama maintains Replimune Group (NASDAQ:REPL) with a Overweight and lowers the price target from $47 to $39.
byBenzinga Newsdesk
April 4, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

JP Morgan analyst Anupam Rama maintains Replimune Group (NASDAQ:REPL) with a Overweight and lowers the price target from $47 to $39.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0